Issue 41, 2018

Co-crystallization of anti-inflammatory pharmaceutical contaminants and rare carboxylic acid–pyridine supramolecular synthon breakdown

Abstract

The reliability of supramolecular synthons in co-crystals involving naproxen and mefenamic acid is investigated. The carboxylic acid⋯pyridine synthon is exceptionally reliable; however, we observe synthon breakdown and a rare pyridyl dimer in a co-crystal with mefenamic acid. A Cambridge Structural Database survey supports the rarity of this motif in acid–bipyridine co-crystals.

Graphical abstract: Co-crystallization of anti-inflammatory pharmaceutical contaminants and rare carboxylic acid–pyridine supramolecular synthon breakdown

Supplementary files

Article information

Article type
Communication
Submitted
03 Sep 2018
Accepted
28 Sep 2018
First published
28 Sep 2018

CrystEngComm, 2018,20, 6377-6381

Co-crystallization of anti-inflammatory pharmaceutical contaminants and rare carboxylic acid–pyridine supramolecular synthon breakdown

Q. Zheng, S. L. Rood, D. K. Unruh and K. M. Hutchins, CrystEngComm, 2018, 20, 6377 DOI: 10.1039/C8CE01492B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements